149 related articles for article (PubMed ID: 9637502)
1. CpG oligodeoxyribonucleotides rescue mature spleen B cells from spontaneous apoptosis and promote cell cycle entry.
Yi AK; Chang M; Peckham DW; Krieg AM; Ashman RF
J Immunol; 1998 Jun; 160(12):5898-906. PubMed ID: 9637502
[TBL] [Abstract][Full Text] [Related]
2. CpG DNA rescue of murine B lymphoma cells from anti-IgM-induced growth arrest and programmed cell death is associated with increased expression of c-myc and bcl-xL.
Yi AK; Hornbeck P; Lafrenz DE; Krieg AM
J Immunol; 1996 Dec; 157(11):4918-25. PubMed ID: 8943396
[TBL] [Abstract][Full Text] [Related]
3. CpG-oligodeoxynucleotide protects immune cells from gamma-irradiation-induced cell death.
Sohn WJ; Lee KW; Choi SY; Chung E; Lee Y; Kim TY; Lee SK; Choe YK; Lee JH; Kim DS; Kwon HJ
Mol Immunol; 2006 Mar; 43(8):1163-71. PubMed ID: 16122803
[TBL] [Abstract][Full Text] [Related]
4. Impact of modifications of heterocyclic bases in CpG dinucleotides on their immune-modulatory activity.
Vollmer J; Weeratna RD; Jurk M; Davis HL; Schetter C; Wüllner M; Wader T; Liu M; Kritzler A; Krieg AM
J Leukoc Biol; 2004 Sep; 76(3):585-93. PubMed ID: 15218053
[TBL] [Abstract][Full Text] [Related]
5. Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA.
Ballas ZK; Rasmussen WL; Krieg AM
J Immunol; 1996 Sep; 157(5):1840-5. PubMed ID: 8757300
[TBL] [Abstract][Full Text] [Related]
6. Modulation of malignant B cell activation and apoptosis by bcl-2 antisense ODN and immunostimulatory CpG ODN.
Jahrsdörfer B; Jox R; Mühlenhoff L; Tschoep K; Krug A; Rothenfusser S; Meinhardt G; Emmerich B; Endres S; Hartmann G
J Leukoc Biol; 2002 Jul; 72(1):83-92. PubMed ID: 12101266
[TBL] [Abstract][Full Text] [Related]
7. Immunostimulatory DNA activates production of type I interferons and interleukin-6 in equine peripheral blood mononuclear cells in vitro.
Wattrang E; Berg M; Magnusson M
Vet Immunol Immunopathol; 2005 Sep; 107(3-4):265-79. PubMed ID: 15955566
[TBL] [Abstract][Full Text] [Related]
8. CpG stimulation of primary mouse B cells is blocked by inhibitory oligodeoxyribonucleotides at a site proximal to NF-kappaB activation.
Lenert P; Stunz L; YI AK; Krieg AM; Ashman RF
Antisense Nucleic Acid Drug Dev; 2001 Aug; 11(4):247-56. PubMed ID: 11572601
[TBL] [Abstract][Full Text] [Related]
9. Rapid immune activation by CpG motifs in bacterial DNA. Systemic induction of IL-6 transcription through an antioxidant-sensitive pathway.
Yi AK; Klinman DM; Martin TL; Matson S; Krieg AM
J Immunol; 1996 Dec; 157(12):5394-402. PubMed ID: 8955187
[TBL] [Abstract][Full Text] [Related]
10. Lovastatin inhibits G1/S transition of normal human B-lymphocytes independent of apoptosis.
Naderi S; Blomhoff R; Myklebust J; Smeland EB; Erikstein B; Norum KR; Blomhoff HK
Exp Cell Res; 1999 Oct; 252(1):144-53. PubMed ID: 10502407
[TBL] [Abstract][Full Text] [Related]
11. Unmethylated CpG-containing oligodeoxynucleotides inhibit apoptosis in WEHI 231 B lymphocytes induced by several agents: evidence for blockade of apoptosis at a distal signalling step.
Macfarlane DE; Manzel L; Krieg AM
Immunology; 1997 Aug; 91(4):586-93. PubMed ID: 9378499
[TBL] [Abstract][Full Text] [Related]
12. CpG oligodeoxynucleotides down-regulate macrophage class II MHC antigen processing.
Chu RS; Askew D; Noss EH; Tobian A; Krieg AM; Harding CV
J Immunol; 1999 Aug; 163(3):1188-94. PubMed ID: 10415013
[TBL] [Abstract][Full Text] [Related]
13. Immunostimulation and anti-DNA antibody production by backbone modified CpG-DNA.
Kim D; Rhee JW; Kwon S; Sohn WJ; Lee Y; Kim DW; Kim DS; Kwon HJ
Biochem Biophys Res Commun; 2009 Feb; 379(2):362-7. PubMed ID: 19103173
[TBL] [Abstract][Full Text] [Related]
14. CpG motifs in bacterial DNA trigger direct B-cell activation.
Krieg AM; Yi AK; Matson S; Waldschmidt TJ; Bishop GA; Teasdale R; Koretzky GA; Klinman DM
Nature; 1995 Apr; 374(6522):546-9. PubMed ID: 7700380
[TBL] [Abstract][Full Text] [Related]
15. Effect of curcumin on cell cycle progression and apoptosis in vascular smooth muscle cells.
Chen HW; Huang HC
Br J Pharmacol; 1998 Jul; 124(6):1029-40. PubMed ID: 9720770
[TBL] [Abstract][Full Text] [Related]
16. Antimetastatic effect of CpG DNA mediated by type I IFN.
Hafner M; Zawatzky R; Hirtreiter C; Buurman WA; Echtenacher B; Hehlgans T; Männel DN
Cancer Res; 2001 Jul; 61(14):5523-8. PubMed ID: 11454702
[TBL] [Abstract][Full Text] [Related]
17. c-Myc protein is stabilized by fibroblast growth factor 2 and destabilized by ACTH to control cell cycle in mouse Y1 adrenocortical cells.
Lepique AP; Moraes MS; Rocha KM; Eichler CB; Hajj GN; Schwindt TT; Armelin HA
J Mol Endocrinol; 2004 Dec; 33(3):623-38. PubMed ID: 15591023
[TBL] [Abstract][Full Text] [Related]
18. Antagonism of immunostimulatory CpG-oligodeoxynucleotides by quinacrine, chloroquine, and structurally related compounds.
Macfarlane DE; Manzel L
J Immunol; 1998 Feb; 160(3):1122-31. PubMed ID: 9570525
[TBL] [Abstract][Full Text] [Related]
19. Suppression of programmed death and G1 arrest in B-cell hybridomas by interleukin-6 is not accompanied by altered expression of immediate early response genes.
Sabourin LA; Hawley RG
J Cell Physiol; 1990 Dec; 145(3):564-74. PubMed ID: 1703172
[TBL] [Abstract][Full Text] [Related]
20. Novel oligodeoxynucleotide agonists of TLR9 containing N3-Me-dC or N1-Me-dG modifications.
Putta MR; Zhu F; Li Y; Bhagat L; Cong Y; Kandimalla ER; Agrawal S
Nucleic Acids Res; 2006; 34(11):3231-8. PubMed ID: 16798912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
